US Stock MarketDetailed Quotes

Greenwich LifeSciences (GLSI)

Watchlist
  • 25.780
  • -0.040-0.15%
Close Apr 10 16:00 ET
  • 25.600
  • -0.180-0.70%
Post 20:01 ET
357.17MMarket Cap-17.66P/E (TTM)

Greenwich LifeSciences (GLSI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.38%-2.67M
-113.11%-2.23M
-2.91%-1.83M
-12.16%-7.27M
14.02%-1.85M
-43.50%-2.58M
-8.36%-1.05M
-14.50%-1.78M
-4.49%-6.48M
0.73%-2.15M
Net income from continuing operations
-55.57%-4.15M
-54.42%-4.03M
-31.75%-3.26M
-77.57%-15.79M
-192.72%-8.04M
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
Depreciation and amortization
--0
-2.99%876
0.00%903
0.00%3.61K
0.00%903
0.00%903
0.00%903
0.00%903
0.00%3.61K
0.00%903
Change In working capital
87.54%-63.61K
-74.35%247.09K
-227.31%-121.21K
3,916.78%1.27M
24,999.31%717.35K
-11,889.76%-510.64K
1,360.36%963.42K
448.35%95.21K
125.76%31.5K
-111.51%-2.88K
-Change in payables and accrued expense
87.54%-63.61K
-74.35%247.09K
-227.31%-121.21K
2,944.49%959.05K
14,368.24%411.07K
-11,889.76%-510.64K
1,360.36%963.42K
448.35%95.21K
125.76%31.5K
-111.51%-2.88K
-Change in other working capital
----
----
----
--306.28K
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-3.38%-2.67M
-113.11%-2.23M
-2.91%-1.83M
-12.16%-7.27M
14.02%-1.85M
-43.50%-2.58M
-8.36%-1.05M
-14.50%-1.78M
-4.49%-6.48M
0.73%-2.15M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
183.82%3.35M
-5.73%2.61M
64.63%492.42K
4.37M
121.83K
1.18M
2.77M
299.12K
0
0
Net common stock issuance
171.55%3.21M
-5.73%2.61M
64.63%492.42K
--4.37M
--121.83K
--1.18M
--2.77M
--299.12K
--0
--0
Cash from discontinued financing activities
Financing cash flow
183.82%3.35M
-5.73%2.61M
64.63%492.42K
--4.37M
--121.83K
--1.18M
--2.77M
--299.12K
--0
--0
Net cash flow
Beginning cash position
-56.75%3.13M
-50.06%2.75M
-41.45%4.09M
-48.10%6.99M
-36.32%5.82M
-33.98%7.22M
-53.77%5.51M
-48.10%6.99M
-50.49%13.47M
-41.53%9.14M
Current changes in cash
148.62%681.88K
-78.18%375.14K
9.53%-1.34M
55.28%-2.9M
19.67%-1.73M
22.11%-1.4M
277.76%1.72M
4.71%-1.48M
52.84%-6.48M
0.73%-2.15M
End cash Position
-34.61%3.81M
-56.75%3.13M
-50.06%2.75M
-41.45%4.09M
-41.45%4.09M
-36.32%5.82M
-33.98%7.22M
-53.77%5.51M
-48.10%6.99M
-48.10%6.99M
Free cash flow
-3.38%-2.67M
-113.11%-2.23M
-2.91%-1.83M
-12.16%-7.27M
14.02%-1.85M
-43.50%-2.58M
-8.36%-1.05M
-14.50%-1.78M
-4.49%-6.48M
0.73%-2.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.38%-2.67M-113.11%-2.23M-2.91%-1.83M-12.16%-7.27M14.02%-1.85M-43.50%-2.58M-8.36%-1.05M-14.50%-1.78M-4.49%-6.48M0.73%-2.15M
Net income from continuing operations -55.57%-4.15M-54.42%-4.03M-31.75%-3.26M-77.57%-15.79M-192.72%-8.04M-11.58%-2.67M-60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M
Depreciation and amortization --0-2.99%8760.00%9030.00%3.61K0.00%9030.00%9030.00%9030.00%9030.00%3.61K0.00%903
Change In working capital 87.54%-63.61K-74.35%247.09K-227.31%-121.21K3,916.78%1.27M24,999.31%717.35K-11,889.76%-510.64K1,360.36%963.42K448.35%95.21K125.76%31.5K-111.51%-2.88K
-Change in payables and accrued expense 87.54%-63.61K-74.35%247.09K-227.31%-121.21K2,944.49%959.05K14,368.24%411.07K-11,889.76%-510.64K1,360.36%963.42K448.35%95.21K125.76%31.5K-111.51%-2.88K
-Change in other working capital --------------306.28K------------------------
Cash from discontinued investing activities
Operating cash flow -3.38%-2.67M-113.11%-2.23M-2.91%-1.83M-12.16%-7.27M14.02%-1.85M-43.50%-2.58M-8.36%-1.05M-14.50%-1.78M-4.49%-6.48M0.73%-2.15M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 183.82%3.35M-5.73%2.61M64.63%492.42K4.37M121.83K1.18M2.77M299.12K00
Net common stock issuance 171.55%3.21M-5.73%2.61M64.63%492.42K--4.37M--121.83K--1.18M--2.77M--299.12K--0--0
Cash from discontinued financing activities
Financing cash flow 183.82%3.35M-5.73%2.61M64.63%492.42K--4.37M--121.83K--1.18M--2.77M--299.12K--0--0
Net cash flow
Beginning cash position -56.75%3.13M-50.06%2.75M-41.45%4.09M-48.10%6.99M-36.32%5.82M-33.98%7.22M-53.77%5.51M-48.10%6.99M-50.49%13.47M-41.53%9.14M
Current changes in cash 148.62%681.88K-78.18%375.14K9.53%-1.34M55.28%-2.9M19.67%-1.73M22.11%-1.4M277.76%1.72M4.71%-1.48M52.84%-6.48M0.73%-2.15M
End cash Position -34.61%3.81M-56.75%3.13M-50.06%2.75M-41.45%4.09M-41.45%4.09M-36.32%5.82M-33.98%7.22M-53.77%5.51M-48.10%6.99M-48.10%6.99M
Free cash flow -3.38%-2.67M-113.11%-2.23M-2.91%-1.83M-12.16%-7.27M14.02%-1.85M-43.50%-2.58M-8.36%-1.05M-14.50%-1.78M-4.49%-6.48M0.73%-2.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More